Alterity Therapeutics Limited Stock Market Value
| PRNAF Stock | USD 0.01 0 71.43% |
| Symbol | Alterity |
Alterity Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alterity Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alterity Therapeutics.
| 12/18/2025 |
| 01/17/2026 |
If you would invest 0.00 in Alterity Therapeutics on December 18, 2025 and sell it all today you would earn a total of 0.00 from holding Alterity Therapeutics Limited or generate 0.0% return on investment in Alterity Therapeutics over 30 days. Alterity Therapeutics is related to or competes with Biostem Technologies, Imugene, Starpharma Holdings, Helix BioPharma, and Satellos Bioscience. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, ... More
Alterity Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alterity Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alterity Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0935 | |||
| Maximum Drawdown | 18.57 |
Alterity Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alterity Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alterity Therapeutics' standard deviation. In reality, there are many statistical measures that can use Alterity Therapeutics historical prices to predict the future Alterity Therapeutics' volatility.| Risk Adjusted Performance | 0.0816 | |||
| Jensen Alpha | 0.8832 | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | 1.28 |
Alterity Therapeutics Backtested Returns
Alterity Therapeutics is out of control given 3 months investment horizon. Alterity Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We were able to analyze nineteen different technical indicators, which can help you to evaluate if expected returns of 1.02% are justified by taking the suggested risk. Use Alterity Therapeutics Mean Deviation of 2.43, risk adjusted performance of 0.0816, and Standard Deviation of 9.2 to evaluate company specific risk that cannot be diversified away. Alterity Therapeutics holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alterity Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Alterity Therapeutics is expected to be smaller as well. Use Alterity Therapeutics standard deviation, kurtosis, period momentum indicator, as well as the relationship between the jensen alpha and day median price , to analyze future returns on Alterity Therapeutics.
Auto-correlation | -92,233,720,368,547,760 |
Near perfect reversele predictability
Alterity Therapeutics Limited has near perfect reversele predictability. Overlapping area represents the amount of predictability between Alterity Therapeutics time series from 18th of December 2025 to 2nd of January 2026 and 2nd of January 2026 to 17th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alterity Therapeutics price movement. The serial correlation of -9.223372036854776E16 indicates that 9.223372036854776E16% of current Alterity Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -92233.7 T | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Alterity Therapeutics lagged returns against current returns
Autocorrelation, which is Alterity Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alterity Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Alterity Therapeutics returns to help us make a trade decision. For example, suppose you find that Alterity Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alterity Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alterity Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alterity Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alterity Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Alterity Therapeutics Lagged Returns
When evaluating Alterity Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alterity Therapeutics pink sheet have on its future price. Alterity Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alterity Therapeutics autocorrelation shows the relationship between Alterity Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Alterity Therapeutics Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Alterity Pink Sheet
Alterity Therapeutics financial ratios help investors to determine whether Alterity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterity with respect to the benefits of owning Alterity Therapeutics security.